Cargando…
Bone fragility in patients with chronic kidney disease
Mineral and bone diseases (MBD) are predominant in patients with chronic kidney disease (CKD) and lead to several bone manifestations, from pain to skeletal fractures. Cumulative traditional clinical risk factors, such as age and gender, in addition to those related to CKD, enhance the risk of comor...
Autores principales: | Cohen-Solal, Martine, Funck-Brentano, Thomas, Ureña Torres, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219138/ https://www.ncbi.nlm.nih.gov/pubmed/32168473 http://dx.doi.org/10.1530/EC-20-0039 |
Ejemplares similares
-
Bone Fragility in Chronic Kidney Disease Stage 3 to 5: The Use of Vitamin D Supplementation
por: Ureña Torres, Pablo Antonio, et al.
Publicado: (2022) -
Bone Fragility Fractures in CKD Patients
por: Pimentel, Ana, et al.
Publicado: (2020) -
Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases
por: Fabre, Stéphanie, et al.
Publicado: (2020) -
The Use of Imaging Techniques in Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD)—A Systematic Review
por: Pimentel, Ana, et al.
Publicado: (2021) -
A review and perspective on the assessment, management and prevention of fragility fractures in patients with osteoporosis and chronic kidney disease
por: Hampson, Geeta, et al.
Publicado: (2021)